Comment Number,Ballot,Chapter,Section,Page #,Line #,Artifact ID,Resource(s),HTML Page name(s),URL,Vote and Type,Sub-category,Tracker #,Existing Wording,Proposed Wording,Ballot Comment,Summary,In person resolution requested,Comment grouping,Schedule,Triage Note,Pubs,Disposition WG,Disposition,Disposition Comment or Retract/Withdraw details,Disposition/Retract/ Withdrawal Date,Mover / seconder,For ,Against,Abstain,Retracted / Withdrawn,Disposition External Organization,Responsible Person,Change Applied,Substantive Change,Submitted By,Organization,On behalf of,Commenter Email,Submitter Tracking ID,Referred To,Received From,Notes,,
1,CDISC Lab,,,,,,,(NA),,A-Q,,,,,"Am I correct that CDISC is emphasizing specimen and patient identification? E.g. CDISC would accept a genetic test result returned that conforms to a profile from the Clinical Genomics WG, EMERGE, mCODE or simply a profile instance of Observation resource. ",Question of specimen and patient focus of CDISC.,No,,,,,Biomedical Research & Regulation,,,,,,,,,,,,,Bret Heale ,Intermountain Healthcare ,,Heale@imail.org ,,,,,,
2,CDISC Lab,,Overview,,,,,overview,http://hl7.org/fhir/uv/cdisc-lab/2019SEP/overview.html#purpose-and-goals-of-the-project,A-T,,,"The purpose of the FHIR to CDISC Laboratory Data Mapping project is to provide organizations with information on consuming data that have been supplied in a FHIR format, and tranforming the data into the CDISC standards that are required for research sponsors.","The purpose of the FHIR to CDISC Laboratory Data Mapping project is to provide organizations with information on consuming data that have been supplied in a FHIR format, and transforming the data into the CDISC standards that are required for research sponsors.",,Corect spelling of 'transforming' in paragraph: ,,_Typo,,,,Biomedical Research & Regulation,Persuasive,,2019-09-14,,,,,,,,,,Mitra Rocca ,Food and Drug Administration ,,mitra.rocca@fda.hhs.gov ,,,,,,
3,CDISC Lab,,4,,,,,usecases,http://hl7.org/fhir/uv/cdisc-lab/2019SEP/overview.html#use-cases,A-S,Clarification,,,,"At the very beginning of this IG, Use Cases are mentioned, but no URL hyperlinks referring the actual use case materials. Suggest to generate corresponding hyperlinks to the actual use cases to be associated with the Use Cases subsection, such as the URL of http://hl7.org/fhir/uv/cdisc-lab/2019SEP/downloads.html#use-case-1-fhir-to-cdisc-lab-xml.  From Chapter 2.

Additionally, the descriptions of the use cases in the ""download"" section should be placed in the ""Overview -> Use Cases"" section. Only hyperlinks pointing to the referred downloadable files are needed (without too much description) in the Download section. ",Move content from uploads page to Overview page.,,,,,,Biomedical Research & Regulation,,,,,,,,,,,,,Mitra Rocca ,Food and Drug Administration ,,mitra.rocca@fda.hhs.gov ,,,,,,
4,CDISC Lab,,Data Standards,,,,,overview,http://hl7.org/fhir/uv/cdisc-lab/2019SEP/overview.html#cdl-project-data-standards,A-S,Enhancement,,,,"Recommend adding BRIDG as one of the artifacts for this FHIR IG in addition to CDASH, SDTM and CDISC lab model  ",Recommend adding BRIDG to scope.,,,,,,Biomedical Research & Regulation,,,,,,,,,,,,,Mitra Rocca ,Food and Drug Administration ,,mitra.rocca@fda.hhs.gov ,,,,,,
